Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Amar Sawhney, Ph.D., President and Chief Executive Officer, will present at two upcoming investor conferences: Jefferies 2016 Healthcare ConferenceTuesday, June 7, 2016 at 8:00 a.m. Eastern TimeThe Grand Hyatt Hotel, New York, NY JMP Securities 2016 Life Sciences
